These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20413594)

  • 1. Split Renilla luciferase protein fragment-assisted complementation (SRL-PFAC) to characterize Hsp90-Cdc37 complex and identify critical residues in protein/protein interactions.
    Jiang Y; Bernard D; Yu Y; Xie Y; Zhang T; Li Y; Burnett JP; Fu X; Wang S; Sun D
    J Biol Chem; 2010 Jul; 285(27):21023-36. PubMed ID: 20413594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and purification of recombinant NRL-Hsp90α and Cdc37-CRL proteins for in vitro Hsp90/Cdc37 inhibitors screening.
    He J; Niu X; Hu C; Zhang H; Guo Y; Ge Y; Wang G; Jiang Y
    Protein Expr Purif; 2013 Nov; 92(1):119-27. PubMed ID: 24056254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium-Throughput Detection of Hsp90/Cdc37 Protein-Protein Interaction Inhibitors Using a Split
    Siddiqui FA; Parkkola H; Manoharan GB; Abankwa D
    SLAS Discov; 2020 Feb; 25(2):195-206. PubMed ID: 31662027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsp90·Cdc37 Complexes with Protein Kinases Form Cooperatively with Multiple Distinct Interaction Sites.
    Eckl JM; Scherr MJ; Freiburger L; Daake MA; Sattler M; Richter K
    J Biol Chem; 2015 Dec; 290(52):30843-54. PubMed ID: 26511315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The split Renilla luciferase complementation assay is useful for identifying the interaction of Epstein-Barr virus protein kinase BGLF4 and a heat shock protein Hsp90.
    Wang J; Guo W; Long C; Zhou H; Wang H; Sun X
    Acta Virol; 2016 Mar; 60(1):62-70. PubMed ID: 26982469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdc37 (cell division cycle 37) restricts Hsp90 (heat shock protein 90) motility by interaction with N-terminal and middle domain binding sites.
    Eckl JM; Rutz DA; Haslbeck V; Zierer BK; Reinstein J; Richter K
    J Biol Chem; 2013 May; 288(22):16032-42. PubMed ID: 23569206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of celastrol to inhibit hsp90 and cdc37 interaction.
    Zhang T; Li Y; Yu Y; Zou P; Jiang Y; Sun D
    J Biol Chem; 2009 Dec; 284(51):35381-9. PubMed ID: 19858214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanism of Protein Kinase Recognition and Sorting by the Hsp90 Kinome-Specific Cochaperone Cdc37.
    Keramisanou D; Aboalroub A; Zhang Z; Liu W; Marshall D; Diviney A; Larsen RW; Landgraf R; Gelis I
    Mol Cell; 2016 Apr; 62(2):260-271. PubMed ID: 27105117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human Cdc37.Hsp90 complex studied by heteronuclear NMR spectroscopy.
    Sreeramulu S; Jonker HR; Langer T; Richter C; Lancaster CR; Schwalbe H
    J Biol Chem; 2009 Feb; 284(6):3885-96. PubMed ID: 19073599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Split
    Keegan BM; Blagg BSJ
    ACS Chem Biol; 2023 Jan; 18(1):184-192. PubMed ID: 36516069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A.
    Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
    BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S30. PubMed ID: 21342561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Domain-mediated dimerization of the Hsp90 cochaperones Harc and Cdc37.
    Roiniotis J; Masendycz P; Ho S; Scholz GM
    Biochemistry; 2005 May; 44(17):6662-9. PubMed ID: 15850399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CDC37: an alternative, kinase-directed strategy for disruption of oncogenic chaperoning.
    Smith JR; Workman P
    Cell Cycle; 2009 Feb; 8(3):362-72. PubMed ID: 19177013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells.
    Zhang T; Hamza A; Cao X; Wang B; Yu S; Zhan CG; Sun D
    Mol Cancer Ther; 2008 Jan; 7(1):162-70. PubMed ID: 18202019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins.
    Smith JR; de Billy E; Hobbs S; Powers M; Prodromou C; Pearl L; Clarke PA; Workman P
    Oncogene; 2015 Jan; 34(1):15-26. PubMed ID: 24292678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a DYRK1A Inhibitor that Induces Degradation of the Target Kinase using Co-chaperone CDC37 fused with Luciferase nanoKAZ.
    Sonamoto R; Kii I; Koike Y; Sumida Y; Kato-Sumida T; Okuno Y; Hosoya T; Hagiwara M
    Sci Rep; 2015 Aug; 5():12728. PubMed ID: 26234946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Role and Hierarchy of the Intermolecular Interactions in Binding of Protein Kinase Clients to the Hsp90-Cdc37 Chaperone: Structure-Based Network Modeling of Allosteric Regulation.
    Stetz G; Verkhivker GM
    J Chem Inf Model; 2018 Feb; 58(2):405-421. PubMed ID: 29432007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atomistic simulations and network-based modeling of the Hsp90-Cdc37 chaperone binding with Cdk4 client protein: A mechanism of chaperoning kinase clients by exploiting weak spots of intrinsically dynamic kinase domains.
    Czemeres J; Buse K; Verkhivker GM
    PLoS One; 2017; 12(12):e0190267. PubMed ID: 29267381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte.
    Ota A; Zhang J; Ping P; Han J; Wang Y
    Circ Res; 2010 Apr; 106(8):1404-12. PubMed ID: 20299663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine.
    Xu W; Mollapour M; Prodromou C; Wang S; Scroggins BT; Palchick Z; Beebe K; Siderius M; Lee MJ; Couvillon A; Trepel JB; Miyata Y; Matts R; Neckers L
    Mol Cell; 2012 Aug; 47(3):434-43. PubMed ID: 22727666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.